Published in BMC Genet on June 03, 2006
A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One (2008) 3.25
Histone regulation in the CNS: basic principles of epigenetic plasticity. Neuropsychopharmacology (2012) 1.33
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet (1993) 51.42
Dissecting the regulatory circuitry of a eukaryotic genome. Cell (1998) 23.62
The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry (2003) 21.70
Implementing a unified approach to family-based tests of association. Genet Epidemiol (2000) 10.96
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev (1996) 6.01
Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2000) 4.54
Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J (1998) 3.99
Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell (2003) 3.06
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Trinucleotide repeats: mechanisms and pathophysiology. Annu Rev Genomics Hum Genet (2000) 2.19
Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells. Genes Dev (2004) 1.63
Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endophenotypes. Br J Psychiatry (2005) 1.55
ATP-dependent nucleosome remodeling complexes: enzymes tailored to deal with chromatin. J Cell Biochem (2004) 1.46
Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet (2005) 1.24
Differential requirement of SWI/SNF for androgen receptor activity. J Biol Chem (2003) 1.23
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry (2002) 1.20
The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann Med (2003) 1.02
Expression of chromatin remodeling factors during neural differentiation. J Biochem (2001) 1.01
Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers. Schizophr Res (2002) 0.91
SMARCA2 and THAP11: potential candidates for polyglutamine disorders as evidenced from polymorphism and protein-folding simulation studies. J Hum Genet (2004) 0.84
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet (2007) 4.54
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet (2009) 2.43
Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry (2006) 2.13
Effects of lowered serotonin transmission on cocaine-induced striatal dopamine response: PET [¹¹C]raclopride study in humans. Br J Psychiatry (2011) 2.11
Alcohol promotes dopamine release in the human nucleus accumbens. Synapse (2003) 2.06
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet (2010) 1.85
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet (2008) 1.78
Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry (2006) 1.78
Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One (2009) 1.78
Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology (2002) 1.72
Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. Br J Psychiatry (2012) 1.70
Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet (2008) 1.66
Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder. Can J Psychiatry (2013) 1.61
NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet B Neuropsychiatr Genet (2005) 1.60
Diagnosing zygosity in infant twins: physical similarity, genotyping, and chorionicity. Twin Res (2003) 1.56
ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet (2013) 1.55
An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord (2006) 1.44
Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms. Psychoneuroendocrinology (2012) 1.42
Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study. J Neurochem (2014) 1.40
Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. J Neurosci (2007) 1.38
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull (2007) 1.38
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry (2002) 1.37
Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology (2002) 1.32
Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet (2011) 1.27
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One (2012) 1.20
Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke (2009) 1.18
First-episode psychosis, early intervention, and outcome: what have we learned? Can J Psychiatry (2005) 1.18
Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. J Psychiatry Neurosci (2005) 1.18
Familial association of neuropsychological traits in patients with generalized and partial seizure disorders. J Clin Exp Neuropsychol (2002) 1.17
Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia. Genomics (2003) 1.17
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry (2010) 1.17
Dopamine genes and attention-deficit hyperactivity disorder: a review. J Psychiatry Neurosci (2003) 1.17
Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology (2002) 1.14
Determinants of help-seeking and system related components of delay in the treatment of first-episode psychosis. Schizophr Res (2007) 1.14
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res (2004) 1.13
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci (2008) 1.10
Maternal alleles acquiring paternal methylation patterns in biparental complete hydatidiform moles. Hum Mol Genet (2003) 1.10
Genome screen to detect linkage to intracranial aneurysm susceptibility genes: the Familial Intracranial Aneurysm (FIA) study. Stroke (2008) 1.10
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J Neurosci (2007) 1.10
Cognitive and clinical moderators of recognition memory in schizophrenia: a meta-analysis. Schizophr Res (2005) 1.10
Is the inattentive subtype of ADHD different from the combined/hyperactive subtype? J Atten Disord (2009) 1.09
Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans. PLoS One (2012) 1.07
Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis. Ann Neurol (2011) 1.07
Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction. Neuropsychopharmacology (2011) 1.07
Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate. Neuropsychopharmacology (2006) 1.07
Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial. J Psychiatry Neurosci (2006) 1.07
Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J Psychiatry Neurosci (2009) 1.07
The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord (2005) 1.07
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. J Clin Psychiatry (2011) 1.06
Cocaine craving, euphoria, and self-administration: a preliminary study of the effect of catecholamine precursor depletion. Behav Neurosci (2005) 1.06
Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biol Psychiatry (2007) 1.06
Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophr Res (2008) 1.06
Association of NPAS3 exonic variation with schizophrenia. Schizophr Res (2010) 1.05
Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.05
Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinology (2012) 1.05
Serotonin-system polymorphisms (5-HTTLPR and -1438G/A) and responses of patients with bulimic syndromes to multimodal treatments. J Clin Psychiatry (2008) 1.05
Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. Eur Arch Psychiatry Clin Neurosci (2011) 1.04
Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res (2003) 1.04
Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. J Psychiatry Neurosci (2007) 1.03
Mutation screening of FOXP2 in individuals diagnosed with autistic disorder. Am J Med Genet A (2003) 1.03
The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype. Alcohol Clin Exp Res (2011) 1.03
alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur Neuropsychopharmacol (2005) 1.03
Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. BMC Psychiatry (2011) 1.02
Associative memory encoding and recognition in schizophrenia: an event-related fMRI study. Biol Psychiatry (2006) 1.02
Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry (2004) 1.02
Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk. Stroke (2012) 1.02
The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Psychophysiology (2011) 1.02